AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.
Research / 27 September 2024
The meeting brought together nearly 300 experts to discuss advancing pharmacovigilance practice and local data-driven decision-making on the continent.
Around the world / 16 September 2024
Medication errors are a key pharmacovigilance issue, especially as patients transition between secondary and primary care as they readjust to life outside of hospital.
Research / 09 September 2024
Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?
In focus / 15 October 2024
The READUS-PV statement is the first-ever guide for reporting disproportionality analyses that are replicable, reliable, and reproducible.
Research / 07 October 2024
AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.
Research / 27 September 2024
How does an economics theory apply to drug safety, and how can we use it to better manage rare, unexpected, and serious adverse drug reactions?
Perspective / 23 September 2024
Research / 27 September 2024
Perspective / 23 September 2024
Video / 17 October 2023
Podcast / 07 October 2024
Podcast / 26 August 2024
Podcast / 02 May 2024
Podcast / 04 March 2024
Podcast / 05 February 2024
Podcast / 21 December 2023
Podcast / 14 November 2023
Podcast / 07 November 2023
Video / 12 October 2023
Video / 12 January 2023
Podcast / 02 October 2023
Podcast / 07 September 2023
Podcast / 30 June 2023
Podcast / 10 May 2023
Podcast / 31 March 2023
Podcast / 23 February 2023
Podcast / 31 January 2023
Video / 14 November 2022
Podcast / 15 December 2022
Podcast / 03 October 2022
Video / 08 March 2022
Video / 04 February 2022
Podcast / 25 August 2022
Video / 17 June 2021
Video / 30 March 2021
Video / 08 June 2020
Video / 23 May 2018